TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.
about
Vaccine adjuvants as potential cancer immunotherapeuticsImproving the clinical impact of biomaterials in cancer immunotherapy.Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsBiology, Therapy and Implications of Tumor Exosomes in the Progression of MelanomaTLR-exosomes exhibit distinct kinetics and effector function.The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.Modifying Dendritic Cell Activation with Plasmonic Nano VectorsApplying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.Roles of exosomes in the normal and diseased eye.Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities.Mimicking biological functionality with polymers for biomedical applications.Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.Use of adjuvants for immunotherapy.Biological roles and potential applications of immune cell-derived extracellular vesicles.Exosome Theranostics: Biology and Translational Medicine.TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles.The Origin and Functions of Exosomes in Cancer.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics.Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma.To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles
P2860
Q26752522-5EEF181E-A07F-4732-BA67-EA7D009758DBQ26766267-50CB4ED2-DAB0-4D5A-9437-1C24FA271BE3Q26767267-94ECDCF1-27DF-4142-A6BC-01DFF3561E09Q28070187-6E591E03-677C-41B9-8402-E2C14850BCE9Q30841825-5873C143-5213-4C64-BEF5-6C4E831682B2Q33648709-3169048C-72A3-4FA1-A698-268DAAE4F636Q33906222-96B44140-0EE6-4E27-8F27-42F00AE42774Q36422761-DF6192A9-BAC9-459B-BADD-250937C48C4AQ38688358-71689A07-D381-4143-82E3-09279C3B4F47Q38694652-02A2FFD9-9C65-4784-88EA-8F095E244764Q38947856-1A9D01F8-6F5E-4005-B369-99A6EBBDB428Q39038679-2E9AA84B-9D3E-4AED-B73B-55F9DB8BDF15Q39094369-BD64A25F-5CCA-488C-BE3A-34BCA4AA4AB3Q40163884-A84FBD51-DC2C-431B-8530-9AE2EA27A51AQ46193686-654277B1-7FFF-4A9C-9396-1F1984CE11F6Q47095746-F2A28697-7AE7-43DC-ABB1-E18513878D66Q49634174-91AEF6B5-65B0-4CCA-86BE-8540375C5C0FQ52608418-4F7E5225-47E9-4E56-B83A-B9C334EDB7EDQ52746279-44E80092-0D9F-4015-980C-3AA4B833BEE3Q55253817-1D74607A-E318-45CD-9F9A-F4DE7BEDDF80Q55257766-469E9826-3D14-46B2-9DE1-1B9904F6248EQ58699153-A58AB4DA-78F6-4EA0-ABF8-A0BA030FA2FF
P2860
TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@ast
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@en
type
label
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@ast
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@en
prefLabel
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@ast
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@en
P2093
P2860
P356
P1433
P1476
TLR-3 stimulation improves ant ...... in a murine model of melanoma.
@en
P2093
David S Wilson
Eleonora Simeoni
Jeffrey A Hubbell
Martina Damo
P2860
P2888
P356
10.1038/SREP17622
P407
P577
2015-12-03T00:00:00Z